Anika Therapeutics
ANIK
ANIK
120 hedge funds and large institutions have $340M invested in Anika Therapeutics in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 42
2.28% less ownership
Funds ownership: 93.82% → 91.54% (-2.3%)
Holders
120
Holding in Top 10
3
Calls
$469K
Puts
$160K
Top Buyers
1 | +$9.01M | |
2 | +$4.5M | |
3 | +$3.05M | |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.19M |
5 |
AFA
Alta Fundamental Advisers
New York
|
+$1.75M |
Top Sellers
1 | -$6.82M | |
2 | -$5.37M | |
3 | -$4.77M | |
4 |
Citadel Advisors
Miami,
Florida
|
-$3.79M |
5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.61M |